Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis
出版年份 2016 全文链接
标题
Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis
作者
关键词
-
出版物
Multiple Sclerosis Journal
Volume 22, Issue 10, Pages 1297-1305
出版商
SAGE Publications
发表日期
2016-01-12
DOI
10.1177/1352458515616701
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis
- (2015) Nicola De Stefano et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Fingolimod effect on brain volume loss independently contributes to its effect on disability
- (2015) MP Sormani et al. Multiple Sclerosis Journal
- Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis
- (2015) E.-W. Radue et al. NEUROLOGY
- Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort
- (2015) Dalia L. Rotstein et al. JAMA Neurology
- Fingolimod effect on brain volume loss independently contributes to its effect on disability
- (2015) MP Sormani et al. Multiple Sclerosis Journal
- No Evidence of Disease Activity: Indirect Comparisons of Oral Therapies for the Treatment of Relapsing–Remitting Multiple Sclerosis
- (2014) Richard Nixon et al. ADVANCES IN THERAPY
- Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsing-remitting multiple sclerosis
- (2014) Douglas L Arnold et al. BMC Neurology
- Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
- (2014) Nicola De Stefano et al. CNS DRUGS
- Mechanisms of white matter damage in multiple sclerosis
- (2014) Hans Lassmann GLIA
- Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2014) Peter A Calabresi et al. LANCET NEUROLOGY
- Disease Activity Free Status
- (2014) Carolyn J. Bevan et al. JAMA Neurology
- Randomized study combining interferon and glatiramer acetate in multiple sclerosis
- (2013) Fred D. Lublin et al. ANNALS OF NEUROLOGY
- Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis
- (2013) Maria Pia Sormani et al. ANNALS OF NEUROLOGY
- Brain atrophy and lesion load predict long term disability in multiple sclerosis
- (2013) Veronica Popescu et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Disease-activity-free status in patients with relapsing–remitting multiple sclerosis treated with daclizumab high-yield process in the SELECT study
- (2013) Eva Havrdova et al. Multiple Sclerosis Journal
- Editors' welcome and a working definition for a multiple sclerosis cure
- (2013) Brenda Banwell et al. Multiple Sclerosis and Related Disorders
- Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple Sclerosis
- (2012) Ernst-Wilhelm Radue ARCHIVES OF NEUROLOGY
- Association between pathological and MRI findings in multiple sclerosis
- (2012) Massimo Filippi et al. LANCET NEUROLOGY
- Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis
- (2011) Gavin Giovannoni et al. LANCET NEUROLOGY
- Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis
- (2011) Luca Prosperini et al. Multiple Sclerosis Journal
- MRI predictors of cognitive outcome in early multiple sclerosis
- (2011) M. S. A. Deloire et al. NEUROLOGY
- Disability Progression in a Clinical Trial of Relapsing-Remitting Multiple Sclerosis
- (2010) Richard A. Rudick et al. ARCHIVES OF NEUROLOGY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- The relation between inflammation and neurodegeneration in multiple sclerosis brains
- (2009) Josa M. Frischer et al. BRAIN
- Gray matter atrophy and disability progression in patients with early relapsing–remitting multiple sclerosis
- (2009) Dana Horakova et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
- (2009) Eva Havrdova et al. LANCET NEUROLOGY
- Brain atrophy as an outcome measure for multiple sclerosis clinical trials: A "no-brainer"?
- (2009) R. A. Rudick et al. NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started